Search

Issue
Title
Authors
Vol 12, No 4 (2012)
Recent Developments of Small Molecule EGFR Inhibitors Based on the Quinazoline Core Scaffolds
Liu Y., Zhang C., Liu Z.
PDF
(Eng)
Vol 10, No 6 (2010)
Epidermal Growth Factor Receptor as a Target for Anti-Cancer Agent Design
Cao J., Fang H., Wang B., Ma C., Xu W.
PDF
(Eng)
Vol 15, No 6 (2015)
MicroRNAs and Targeted Therapies in Non-small Cell Lung Cancer: Minireview
Tibaldi C., D'Incecco A., Lagana A.
PDF
(Eng)
Vol 11, No 8 (2011)
Targeted Toxins for Glioblastoma Multiforme: Pre-Clinical Studies and Clinical Implementation
Candolfi M., M. Kroeger K., Xiong W., Liu C., Puntel M., Yagiz K., Ghulam Muhammad A., Mineharu Y., Foulad D., Wibowo M., Assi H., J. Baker G., R. Lowenstein P., G. Castro M.
PDF
(Eng)
Vol 24, No 17 (2024)
A Novel Tryptanthrin Derivative D6 Induces Apoptosis and DNA Damage in Non-small-cell Lung Cancer Cells Through Regulating the EGFR Pathway
Long H., Zhang G., Zhou Y., Qin L., Zhu D., Chen J., Liu B., Tan H., Chen D., Li Z., Li C., Wang Z.
PDF
(Eng)
Vol 15, No 2 (2015)
Design, Synthesis and Biological Evaluation of Quinoxalin-2(1H)-one Derivatives as EGFR Tyrosine Kinase Inhibitors
Qin X., Han X., Hu L., Li Z., Geng Z., Wang Z., Zeng C., Xiao X.
PDF
(Eng)
Vol 14, No 5 (2014)
Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
Passaro A., Alesini D., Pochesci A., Cortesi E.
PDF
(Eng)
Vol 10, No 10 (2010)
Focal Adhesion Kinase as a Cancer Therapy Target
M. Golubovskaya V.
PDF
(Eng)
Vol 13, No 3 (2013)
Treatment Directed to Signalling Molecules in Patients with Advanced Differentiated Thyroid Cancer
M.G. Saez J.
PDF
(Eng)
Vol 25, No 4 (2025)
Novel Quinoline Nitrate Derivatives: Synthesis, Characterization, and Evaluation of their Anticancer Activity with a Focus on Molecular Docking and NO Release
Thanneeru V., Panigrahi N.
PDF
(Eng)
Vol 13, No 3 (2013)
Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives
Bozec A., Peyrade F., Milano G.
PDF
(Eng)
Vol 25, No 11 (2025)
Anti-metastasis Effects and Mechanism of Action of Curcumin Analog (2E,6E)-2,6-bis(2,3-dimethoxybenzylidene) Cyclohexanone (DMCH) on the SW620 Colorectal Cancer Cell Line
Rahim N., Hussin Y., Aziz M., Masarudin M., Gani S., Akhtar M., Abd. Rahman N.M., Alitheen N.
PDF
(Eng)
Vol 23, No 19 (2023)
A Combination of EGFR Inhibitors and AE-PDT Could Synergistically Suppress Breast Cancer Progression
Niu Y., Guo X., Han W., Han X., Li K., Tian S., Zhu Y., Bai D., Chen Q.
PDF
(Eng)
Vol 16, No 12 (2016)
Pyrrolidino Analogues of Gefitinib with Improved EGFR Inhibition, Cancer Cell Cytotoxicity, and Pharmacokinetic Properties
Fang J., Xu Z., Zhang Y., Zhang W., Liu B., Fang Y., Sun T.
PDF
(Eng)
Vol 12, No 2 (2012)
Are KRAS/BRAF Mutations Potent Prognostic and/or Predictive Biomarkers in Colorectal Cancers?
Yokota T.
PDF
(Eng)
Vol 23, No 11 (2023)
Novel 5-bromoindole-2-carboxylic Acid Derivatives as EGFR Inhibitors: Synthesis, Docking Study, and Structure Activity Relationship
Hassan O., Kubba A., Tahtamouni L.
PDF
(Eng)
Vol 16, No 12 (2016)
4-Anilinoquinazoline Derivatives with Epidermal Growth Factor Receptor Inhibitor Activity
Liu F., Tang B., Liu H., Li L., Liu G., Cheng Y., Xu Y., Chen W., Huang Y.
PDF
(Eng)
Vol 11, No 8 (2011)
Erlotinib in Glioblastoma - Lost in Translation?
Karpel-Massler G., Andrew Westhoff M., E. Kast R., Rainer Wirtz C., Halatsch M.
PDF
(Eng)
Vol 23, No 11 (2023)
Osimertinib Induces the Opposite Effect of Proliferation and Migration in the Drug Resistance of EGFR-T790M Non-small Cell Lung Cancer Cells
Wang R., Chang C., Chen C., Liu K., Chao J.
PDF
(Eng)
1 - 19 of 19 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"